DiLA2 Delivery Technology

The DiLA2 Technology is a proprietary means for creating novel liposome formulations from dialkylated amino acids for delivery of UsiRNA. This technology allows for modifying key aspects of the delivery system such as charge, linker and acyl chains such that the properties of the liposome can be optimized for delivery to a target tissue of interest. In addition, the technology is designed to permit inclusion of peptides to improve a variety of delivery characteristics including encapsulation of nanoparticles, cellular uptake, endosomal release and cell/tissue targeting.

Share Print